FRCPath Haem Part 1 MCQ-Haemostasis 177

A 12yr-old boy with severe haemophilia A is receiving standard recombinant factor VIII prophylaxis. Team plans to switch him to EHL Product. Correct statement?

• EHL product are introduced at diagnosis to prevent Inhibitor
• EHL factors achieve prolonged circulation by PEGylation
• EHL products are only suitable for pt with inhibitors
• EHL half life is 4-5 folds vs standard products

See All Options

Want to read more?

Subscribe to hematomorph.com to keep reading this exclusive post.

Subscribe Now